|
1.
|
Nathke I and Rocha S: Antagonistic
crosstalk between APC and HIF-1alpha. Cell Cycle. 10:1545–1547.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Yoo YG, Christensen J, Gu J and Huang LE:
HIF-1alpha mediates tumor hypoxia to confer a perpetual mesenchymal
phenotype for malignant progression. Sci Signal.
4:pt42011.PubMed/NCBI
|
|
3.
|
Haase VH: Hypoxia-inducible factors in the
kidney. Am J Physiol Renal Physiol. 291:F271–F281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Henze AT and Acker T: Feedback regulators
of hypoxia-inducible factors and their role in cancer biology. Cell
Cycle. 9:2749–2763. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Berra E, Ginouves A and Pouyssegur J: The
hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia
signalling. EMBO Rep. 7:41–45. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Koh MY and Powis G: Passing the baton: the
HIF switch. Trends Biochem Sci. 37:364–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Yoo YG, Christensen J and Huang LE:
HIF-1alpha confers aggressive malignant traits on human tumor cells
independent of its canonical transcriptional function. Cancer Res.
71:1244–1252. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Loboda A, Jozkowicz A and Dulak J: HIF-1
and HIF-2 transcription factors - similar but not identical. Mol
Cells. 29:435–442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Rohwer N and Cramer T: Hypoxia-mediated
drug resistance: novel insights on the functional interaction of
HIFs and cell death pathways. Drug Resist Updat. 14:191–201. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Heddleston JM, Li Z, Lathia JD, Bao S,
Hjelmeland AB and Rich JN: Hypoxia inducible factors in cancer stem
cells. Br J Cancer. 102:789–795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Tafani M, Schito L, Pellegrini L, et al:
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell
invasion through phosphorylation of Erk1/2 and Akt and nuclear
translocation of NF-{kappa}B. Carcinogenesis. 32:1167–1175.
2011.PubMed/NCBI
|
|
13.
|
Yamakuchi M, Yagi S, Ito T and Lowenstein
CJ: MicroRNA-22 regulates hypoxia signaling in colon cancer cells.
PLoS One. 6:e202912011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Zhdanov AV, Dmitriev RI, Golubeva AV,
Gavrilova SA and Papkovsky DB: Chronic hypoxia leads to a
glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells.
Biochim Biophys Acta. 1830:3553–3569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Petrella BL, Lohi J and Brinckerhoff CE:
Identification of membrane type-1 matrix metalloproteinase as a
target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau
renal cell carcinoma. Oncogene. 24:1043–1052. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Koh MY, Lemos RJ, Liu X and Powis G: The
hypoxia-associated factor switches cells from HIF-1alpha- to
HIF-2alpha-dependent signaling promoting stem cell characteristics,
aggressive tumor growth and invasion. Cancer Res. 71:4015–4027.
2011. View Article : Google Scholar
|
|
17.
|
Li Z and Rich JN: Hypoxia and hypoxia
inducible factors in cancer stem cell maintenance. Curr Top
Microbiol Immunol. 345:21–30. 2010.PubMed/NCBI
|
|
18.
|
Yeung TM, Gandhi SC and Bodmer WF: Hypoxia
and lineage specification of cell line-derived colorectal cancer
stem cells. Proc Natl Acad Sci USA. 108:4382–4387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Yeramian A, Santacana M, Sorolla A, et al:
Nuclear factor-kappaB2/p100 promotes endometrial carcinoma cell
survival under hypoxia in a HIF-1alpha independent manner. Lab
Invest. 91:859–871. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Xue Y, Li NL, Yang JY, Chen Y, Yang LL and
Liu WC: Phosphatidylinositol 3’-kinase signaling pathway is
essential for Rac1-induced hypoxia-inducible factor-1(alpha) and
vascular endothelial growth factor expression. Am J Physiol Heart
Circ Physiol. 300:H2169–H2176. 2011.
|
|
21.
|
Nys K, Maes H, Dudek AM and Agostinis P:
Uncovering the role of hypoxia inducible factor-1alpha in skin
carcinogenesis. Biochim Biophys Acta. 1816:1–12. 2011.PubMed/NCBI
|
|
22.
|
Ghosh G, Wang VY, Huang DB and Fusco A:
NF-kappaB regulation: lessons from structures. Immunol Rev.
246:36–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
van Uden P, Kenneth NS, Webster R, Muller
HA, Mudie S and Rocha S: Evolutionary conserved regulation of
HIF-1beta by NF-kappaB. PLoS Genet. 7:e10012852011.PubMed/NCBI
|
|
24.
|
Sun SC: The noncanonical NF-kappaB
pathway. Immunol Rev. 246:125–140. 2012.
|
|
25.
|
Paliwal P, Arora D and Mishra AK:
Epithelial mesenchymal transition in urothelial carcinoma: twist in
the tale. Indian J Pathol Microbiol. 55:443–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Jing Y, Han Z, Zhang S, Liu Y and Wei L:
Epithelial-mesenchymal transition in tumor microenvironment. Cell
Biosci. 1:292011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wu ST, Sun GH, Hsu CY, et al: Tumor
necrosis factor-alpha induces epithelial-mesenchymal transition of
renal cell carcinoma cells via a nuclear factor kappa B-independent
mechanism. Exp Biol Med. 236:1022–1029. 2011. View Article : Google Scholar
|
|
28.
|
Harhaj EW and Dixit VM: Regulation of
NF-kappaB by deubiquitinases. Immunol Rev. 246:107–124.
2012.PubMed/NCBI
|
|
29.
|
Gilmore TD and Wolenski FS: NF-kappaB:
where did it come from and why? Immunol Rev. 246:14–35. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Kanarek N and Ben-Neriah Y: Regulation of
NF-kappaB by ubiquitination and degradation of the IkappaBs.
Immunol Rev. 246:77–94. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Brennan P and O’Neill LA:
2-mercaptoethanol restores the ability of nuclear factor kappa B
(NF kappa B) to bind DNA in nuclear extracts from interleukin
1-treated cells incubated with pyrollidine dithiocarbamate (PDTC).
Evidence for oxidation of glutathione in the mechanism of
inhibition of NF kappa B by PDTC. Biochem J. 320:975–981. 1996.
|
|
32.
|
Hayakawa M, Miyashita H, Sakamoto I, et
al: Evidence that reactive oxygen species do not mediate NF-kappaB
activation. EMBO J. 22:3356–3366. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Julien S, Puig I, Caretti E, et al:
Activation of NF-kappaB by Akt upregulates Snail expression and
induces epithelium mesenchyme transition. Oncogene. 26:7445–7456.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Vaupel P and Mayer A: Hypoxia in cancer:
significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Weidemann A and Johnson RS: Biology of
HIF-1alpha. Cell Death Differ. 15:621–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Saito T and Kawaguchi H: HIF-2alpha as a
possible therapeutic target of osteoarthritis. Osteoarthritis
Cartilage. 18:1552–1556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Uchida T, Rossignol F, Matthay MA, et al:
Prolonged hypoxia differentially regulates hypoxia-inducible factor
(HIF)-1alpha and HIF-2alpha expression in lung epithelial cells:
implication of natural antisense HIF-1alpha. J Biol Chem.
279:14871–14878. 2004. View Article : Google Scholar
|
|
38.
|
Myllyharju J and Schipani E: Extracellular
matrix genes as hypoxia-inducible targets. Cell Tissue Res.
339:19–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Jiang H, Zhu Y, Xu H, Sun Y and Li Q:
Activation of hypoxiainducible factor-1alpha via nuclear
factor-kappa B in rats with chronic obstructive pulmonary disease.
Acta Biochim Biophys Sin. 42:483–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Levidou G, Saetta AA, Korkolopoulou P, et
al: Clinical significance of nuclear factor (NF)-kappaB levels in
urothelial carcinoma of the urinary bladder. Virchows Arch.
452:295–304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Gorlach A and Bonello S: The cross-talk
between NF-kappaB and HIF-1: further evidence for a significant
liaison. Biochem J. 412:e17–e19. 2008.PubMed/NCBI
|
|
42.
|
Taylor CT and Cummins EP: The role of
NF-kappaB in hypoxia-induced gene expression. Ann NY Acad Sci.
1177:178–184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
van Uden P, Kenneth NS and Rocha S:
Regulation of hypoxiainducible factor-1alpha by NF-kappaB. Biochem
J. 412:477–484. 2008.PubMed/NCBI
|
|
44.
|
Nam SY, Ko YS, Jung J, et al: A
hypoxia-dependent upregulation of hypoxia-inducible factor-1 by
nuclear factor-kappaB promotes gastric tumour growth and
angiogenesis. Br J Cancer. 104:166–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
